Literature DB >> 3502682

Bone turnover in spinal osteoporosis.

J Pødenphant1, J S Johansen, K Thomsen, B J Riis, A Leth, C Christiansen.   

Abstract

We have investigated biochemical indices of bone formation and bone resorption: serum alkaline phosphatase (sAP) plasma bone Gla protein (pBGP), fasting urinary hydroxyproline corrected for creatinine (FuHP/Cr), and fasting urinary calcium corrected for creatinine (FuCa/Cr) in 43 postmenopausal women with spinal fractures. Furthermore, histomorphometric indices of bone resorption and bone formation, as well as whole body retention (WBR) of 99m-technetium-diphosphonate (99mTc-DP), were determined. The results are compared to pre- and postmenopausal normal subjects. The results showed that indices of bone formation were mutually correlated except for sAP vs. WBR. sAP, WBR, and pBGP increased with age. sAP and WBR were not different between osteoporotics and age-matched controls, while pBGP and probably histological indices of bone formation were lower in osteoporotics than in age-matched controls. pBGP--and to a lesser extent sAP--were significantly correlated with all histological parameters reflecting bone formation. Finally, biochemical indices of bone resorption were high in osteoporotic patients and poorly correlated with histological bone resorption. The discrepancy between biochemical markers of bone formation may be related to the low sensitivity of sAP and WBR. Conversely, pBGP, sAP, and WBR may reflect different aspects of osteoblastic activity and bone mineralization. Finally, our data suggest that bone turnover increases with aging and that osteoporotic patients have higher bone resorption and probably lower bone formation than age-matched controls.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3502682     DOI: 10.1002/jbmr.5650020606

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  14 in total

Review 1.  Complications of long-term home total parenteral nutrition: their identification, prevention and treatment.

Authors:  A L Buchman
Journal:  Dig Dis Sci       Date:  2001-01       Impact factor: 3.199

2.  Serum markers of bone formation in parenteral nutrition patients.

Authors:  E W Lipkin; S M Ott; G L Klein; L J Deftos
Journal:  Calcif Tissue Int       Date:  1990-08       Impact factor: 4.333

Review 3.  Heterogeneity of osteoporotic syndromes and the response to calcitonin therapy.

Authors:  L V Avioli
Journal:  Calcif Tissue Int       Date:  1991       Impact factor: 4.333

4.  Isotope retention for assessment of bone turnover in involutional osteoporosis.

Authors:  M Passeri; E Palummeri; M C Baroni; F Quaini; A Quintavalla; M Barbagallo; D Franchini; D Ugolotti
Journal:  Clin Rheumatol       Date:  1989-06       Impact factor: 2.980

5.  Role of vitamin D metabolites in the prevention of the osteopenia induced by ovariectomy in the axial and appendicular skeleton of the rat.

Authors:  R G Erben; B Kohn; H Weiser; F Sinowatz; W A Rambeck
Journal:  Z Ernahrungswiss       Date:  1990-12

6.  Long-term effects of ovariectomy and aging on the rat skeleton.

Authors:  T J Wronski; L M Dann; K S Scott; M Cintrón
Journal:  Calcif Tissue Int       Date:  1989-12       Impact factor: 4.333

7.  Vitamin D metabolites prevent vertebral osteopenia in ovariectomized rats.

Authors:  R G Erben; H Weiser; F Sinowatz; W A Rambeck; H Zucker
Journal:  Calcif Tissue Int       Date:  1992-03       Impact factor: 4.333

8.  Bone turnover in postmenopausal osteoporosis. Effect of calcitonin treatment.

Authors:  R Civitelli; S Gonnelli; F Zacchei; S Bigazzi; A Vattimo; L V Avioli; C Gennari
Journal:  J Clin Invest       Date:  1988-10       Impact factor: 14.808

9.  Evaluation of bone turnover in type I osteoporosis using biochemical markers specific for both bone formation and bone resorption.

Authors:  R Eastell; S P Robins; T Colwell; A M Assiri; B L Riggs; R G Russell
Journal:  Osteoporos Int       Date:  1993-09       Impact factor: 4.507

Review 10.  Biochemical markers of bone turnover for the clinical investigation of osteoporosis.

Authors:  P D Delmas
Journal:  Osteoporos Int       Date:  1993       Impact factor: 4.507

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.